Global CRISPR And CRISPR-Associated (Cas) Genes Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 104901
- Pages: 116
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global CRISPR And CRISPR-Associated (Cas) Genes market in this environment.
In terms of revenue, this research report indicated that the global CRISPR And CRISPR-Associated (Cas) Genes market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of CRISPR And CRISPR-Associated (Cas) Genes industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Caribou Biosciences aims at producing XX K Units CRISPR And CRISPR-Associated (Cas) Genes in 2020, with XX % production to take place in global market, Addgene accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of CRISPR And CRISPR-Associated (Cas) Genes Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in CRISPR And CRISPR-Associated (Cas) Genes Market
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
...
Major Type of CRISPR And CRISPR-Associated (Cas) Genes Covered in Prudent Markets report:
Type I
Type II
Application Segments Covered in Prudent Markets Market
Application 1
Application 2
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China CRISPR And CRISPR-Associated (Cas) Genes Market
3.1.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU CRISPR And CRISPR-Associated (Cas) Genes Market
3.2.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA CRISPR And CRISPR-Associated (Cas) Genes Market
3.3.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Market
3.4.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India CRISPR And CRISPR-Associated (Cas) Genes Market
3.5.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market
3.6.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America CRISPR And CRISPR-Associated (Cas) Genes Market
3.7.1 Top Companies leading CRISPR And CRISPR-Associated (Cas) Genes Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America CRISPR And CRISPR-Associated (Cas) Genes Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 CRISPR And CRISPR-Associated (Cas) Genes Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on CRISPR And CRISPR-Associated (Cas) Genes Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2021-2027)
5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Value and Growth Rate (2021-2027)
6 CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis
6.1 Caribou Biosciences
6.1.1 Caribou Biosciences Company Profiles
6.1.2 Caribou Biosciences Product Introduction
6.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Addgene
6.2.1 Addgene Company Profiles
6.2.2 Addgene Product Introduction
6.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 CRISPR THERAPEUTICS
6.3.1 CRISPR THERAPEUTICS Company Profiles
6.3.2 CRISPR THERAPEUTICS Product Introduction
6.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Merck KGaA
6.4.1 Merck KGaA Company Profiles
6.4.2 Merck KGaA Product Introduction
6.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Mirus Bio LLC
6.5.1 Mirus Bio LLC Company Profiles
6.5.2 Mirus Bio LLC Product Introduction
6.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Editas Medicine
6.6.1 Editas Medicine Company Profiles
6.6.2 Editas Medicine Product Introduction
6.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Takara Bio USA
6.7.1 Takara Bio USA Company Profiles
6.7.2 Takara Bio USA Product Introduction
6.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Company Profiles
6.8.2 Thermo Fisher Scientific Product Introduction
6.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Horizon Discovery Group
6.9.1 Horizon Discovery Group Company Profiles
6.9.2 Horizon Discovery Group Product Introduction
6.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Intellia Therapeutics
6.10.1 Intellia Therapeutics Company Profiles
6.10.2 Intellia Therapeutics Product Introduction
6.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 GE Healthcare Dharmacon
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
